Skip to main content
. 2014 Jul 8;14:491. doi: 10.1186/1471-2407-14-491

Figure 2.

Figure 2

Comparison of local-regional progression-free survival between patients who underwent four to five cycles of chemotherapy concurrently with radiotherapy at doses of ≥63 Gy and patients who received other treatment regimens.